Research location
Galati
Galați County, Romania
Advertisement
Research activity in Galati
Galați County, RomaniaCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 11 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Galati
10 linked trials · page 1 of 1A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightNCT05929066 · 2023-07-10 · 1 site observation
COMPLETED
Improvement of a Digital Health Platform for Remote Monitoring of Patients With Heart FailureNCT05708846 · 2023-05-18 · 1 site observation
COMPLETED
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisNCT03915964 · 2019-04-25 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesNCT03882970 · 2019-04-01 · 1 site observation
COMPLETED
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesNCT01606007 · 2012-07-01 · 1 site observation
COMPLETED
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes MellitusNCT01494987 · 2012-01-01 · 1 site observation
COMPLETED
Ranolazine Monotherapy in Subjects With Type 2 Diabetes MellitusNCT01472185 · 2011-11-01 · 2 site observations
COMPLETED
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsNCT00789854 · 2008-11-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes MellitusNCT00690638 · 2008-07-01 · 1 site observation
COMPLETED
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to RisperidoneNCT00600756 · 2008-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.